BriaCell Therapeutics Corp. (BCTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BriaCell Therapeutics Cor...

    NASDAQ: BCTX · Real-Time Price · USD
    11.19
    0.48 (4.48%)
    At close: Sep 26, 2025, 1:15 PM

    BriaCell Therapeutics Income Statement

    Financials in CAD. Fiscal year is August - July.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 114.04K 20.49K 19.39K 19.44K
    Gross Profit
    		 -114.04K -20.49K -19.39K -19.44K
    Operating Income
    		 -46.02K -23.27M -15.29M -6.97M
    Interest Income
    		 391.49K 891.21K 136.73K 4.01K
    Pretax Income
    		 -6.81K -20.3M -26.84M -13.82M
    Net Income
    		 -6.62K -20.3M -11.58M -2.9M
    Selling & General & Admin
    		 9.18K 7.94M 7.27M 6.18K
    Research & Development
    		 37.53K 15.34M 10.27K 2.02M
    Other Expenses
    		 -685 -763 -396 -1.33M
    Operating Expenses
    		 46.02K 23.27M 19.58K 6.97M
    Interest Expense
    		 n/a n/a 979.00 46.09K
    Selling & Marketing Expenses
    		 685.30 n/a n/a n/a
    Cost & Expenses
    		 46.02K 23.27M 15.29M 6.97M
    Income Tax Expense
    		 n/a -153K 30.73K 6.58M
    Shares Outstanding (Basic)
    		 1.1M 1.04M 1.03M 301.31K
    Shares Outstanding (Diluted)
    		 1.1M 1.04M 1.03M 301.31K
    EPS (Basic)
    		 -4.28 -19.79 -25.7 -46.73
    EPS (Diluted)
    		 -4.28 -19.79 -25.7 -46.73
    EBITDA
    		 -45.91K -22.37M -34.05M -6.95M
    EBIT
    		 -46.02K -27.24M -34.07M -8.71K
    Depreciation & Amortization
    		 115.84 15.27K 15.27K 15.26K

    Add to Watchlist